• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

APE雾化器——一种用于将颗粒状锝99m二乙三胺五乙酸靶向输送至肺泡的新型输送系统。

The APE nebuliser--a new delivery system for the alveolar targeting of particulate technetium 99m diethylene triamine penta-acetic acid.

作者信息

Miller R F, Jarritt P H, Lui D, Kidery J, Semple S J, Ell P J

机构信息

Department of Medicine, University College and Middlesex School of Medicine, Middlesex Hospital, London, UK.

出版信息

Eur J Nucl Med. 1991;18(3):164-70. doi: 10.1007/BF02262726.

DOI:10.1007/BF02262726
PMID:2040339
Abstract

We report the validation of a new delivery system--aerosol production equipment (known by the acronym APE), which generates a particulate aerosol of technetium 99m diethylene triamine penta-acetic acid (DTPA) with a mass-median aerodynamic diameter of 0.35 microns and a geometric standard deviation of 1.8 Twenty subjects were studied; in group 1 were 12 healthy men with normal spirometry; in group 2 were 8 men with AIDS who had mildly abnormal lung function following an episode of pneumocystis pneumonia-spirometry FEV1 3.08 (0.73) L, FVC 4.83 (0.82) L [mean (SD)]. The APE nebulizer was used to form a particulate aerosol with 200 MBq of 99mTc DTPA, which was collected in a 35 1 reservoir of air, which was subsequently inhaled. The mean (SD) inhalation time was 4.7 (0.44) min. The output of the nebulizer (% of activity inhaled) was 82%. Using planar imaging, the penetration index (right lung) in group 1 was 0.93 (0.18), mean (SD), and in group 2 it was 0.91 (0.12). There was virtually no tracheal deposition and extrapulmonary deposition (oropharynx and stomach) was less than 5% of the aerosol delivered. Single-photon emission tomography (SPET) studies carried out in five patients from group 1 confirmed homogeneous intrapulmonary deposition of 99mTc-DTPA. In view of the excellent intrapulmonary deposition of 99mTc-DTPA produced by the APE nebulizer, it may provide an alternative to conventional ventilation studies using radioactive gases.

摘要

我们报告了一种新型输送系统——气溶胶生成设备(简称为APE)的验证情况,该设备可产生质量中值空气动力学直径为0.35微米、几何标准差为1.8的锝99m二乙三胺五乙酸(DTPA)颗粒气溶胶。对20名受试者进行了研究;第1组为12名肺活量测定正常的健康男性;第2组为8名艾滋病男性患者,他们在卡氏肺孢子虫肺炎发作后肺功能轻度异常——肺活量测定第1秒用力呼气量(FEV1)为3.08(0.73)升,用力肺活量(FVC)为4.83(0.82)升[均值(标准差)]。使用APE雾化器用200MBq的99mTc DTPA形成颗粒气溶胶,该气溶胶收集在35升的空气储器中,随后被吸入。平均(标准差)吸入时间为4.7(0.44)分钟。雾化器的输出(吸入活性的百分比)为82%。使用平面成像,第1组的渗透指数(右肺)为0.93(0.18),均值(标准差),第2组为0.91(0.12)。几乎没有气管沉积,肺外沉积(口咽和胃)小于输送气溶胶的5%。对第1组的5名患者进行的单光子发射断层扫描(SPET)研究证实了99mTc-DTPA在肺内的均匀沉积。鉴于APE雾化器产生的99mTc-DTPA在肺内的出色沉积,它可能为使用放射性气体的传统通气研究提供一种替代方法。

相似文献

1
The APE nebuliser--a new delivery system for the alveolar targeting of particulate technetium 99m diethylene triamine penta-acetic acid.APE雾化器——一种用于将颗粒状锝99m二乙三胺五乙酸靶向输送至肺泡的新型输送系统。
Eur J Nucl Med. 1991;18(3):164-70. doi: 10.1007/BF02262726.
2
Deposition of aqueous aerosol of technetium-99m diethylene triamine penta-acetic acid generated and delivered by a novel system (AERx) in healthy subjects.通过一种新型系统(AERx)产生并输送的锝-99m二乙三胺五乙酸水性气雾剂在健康受试者中的沉积情况。
Eur J Nucl Med. 1999 Apr;26(4):320-7. doi: 10.1007/s002590050393.
3
In vivo deposition study of a new generation nebuliser utilising hybrid resonant acoustic (HYDRA) technology.利用混合谐振声学(HYDRA)技术的新一代雾化器体内沉积研究。
Int J Pharm. 2020 Apr 30;580:119196. doi: 10.1016/j.ijpharm.2020.119196. Epub 2020 Mar 4.
4
Optimising technetium 99m diethylene triamine penta-acetate lung clearance in patients with the acquired immunodeficiency syndrome.
Eur J Nucl Med. 1991;18(4):235-40. doi: 10.1007/BF00186646.
5
Assessment of alveolar epithelial permeability in Behçet's disease with 99mTc-DTPA aerosol scintigraphy.用99mTc-DTPA气溶胶闪烁显像评估白塞病患者的肺泡上皮通透性。
Ann Nucl Med. 2008 Jun;22(5):349-55. doi: 10.1007/s12149-007-0138-4. Epub 2008 Jul 4.
6
99mTc-DTPA aerosol for same-day post-perfusion ventilation imaging: results of a multicentre study.
Eur J Nucl Med. 1993 Jan;20(1):4-9. doi: 10.1007/BF02261238.
7
Delivery and retention of an insulin aerosol produced by a new jet nebulizer.一种新型喷射雾化器产生的胰岛素气雾剂的递送与留存
J Aerosol Med. 1995 Fall;8(3):243-54. doi: 10.1089/jam.1995.8.243.
8
Aerosol deposition and clearance measurement: a novel technique using dynamic SPET.气溶胶沉积与清除测量:一种使用动态单光子发射计算机断层扫描的新技术。
Eur J Nucl Med. 2001 Sep;28(9):1365-72. doi: 10.1007/s002590100586.
9
Aerosolized protein delivery in asthma: gamma camera analysis of regional deposition and perfusion.哮喘中的雾化蛋白递送:区域沉积和灌注的γ相机分析
J Aerosol Med. 2001 Summer;14(2):185-95. doi: 10.1089/08942680152484117.
10
Technetium-99m DTPA aerosol and gallium scanning in acquired immune deficiency syndrome.
Clin Nucl Med. 1987 Jul;12(7):501-6. doi: 10.1097/00003072-198707000-00002.

引用本文的文献

1
Evaluation of alveolar permeability and lung ventilation in patients with chronic renal failure using Tc-99m DTPA radioaerosol inhalation lung scintigraphy.
Lung. 1996;174(3):153-8. doi: 10.1007/BF00173307.
2
99mTc-DTPA aerosol for same-day post-perfusion ventilation imaging: results of a multicentre study.
Eur J Nucl Med. 1993 Jan;20(1):4-9. doi: 10.1007/BF02261238.
3
Aerosols for therapy and diagnosis.用于治疗和诊断的气雾剂。
Eur J Nucl Med. 1993 Dec;20(12):1201-13. doi: 10.1007/BF00171019.
4

本文引用的文献

1
DISTRIBUTION OF PULMONARY VENTILATION DETERMINED BY RADIOISOTOPE SCANNING. A PRELIMINARY REPORT.放射性同位素扫描测定肺通气分布。初步报告。
Am J Roentgenol Radium Ther Nucl Med. 1965 Aug;94:807-14.
2
FACTORS AFFECTING REGIONAL DISTRIBUTION OF VENTILATION AND PERFUSION IN THE LUNG.影响肺通气与灌注区域分布的因素
J Appl Physiol. 1964 May;19:395-402. doi: 10.1152/jappl.1964.19.3.395.
3
EVALUATION OF INHALATION HAZARDS BASED UPON THE RESPIRABLE DUST CONCEPT AND THE PHILOSOPHY AND APPLICATION OF SELECTIVE SAMPLING.
Pulmonary nuclear medicine.肺核医学
Eur J Nucl Med. 1992;19(5):355-68. doi: 10.1007/BF00177058.
Am Ind Hyg Assoc J. 1964 May-Jun;25:213-36. doi: 10.1080/00028896409342581.
4
Aerosols and humidity therapy. Generation and respiratory deposition of therapeutic aerosols.气雾剂与湿化疗法。治疗性气雾剂的产生及呼吸道沉积。
Am Rev Respir Dis. 1980 Nov;122(5 Pt 2):71-7. doi: 10.1164/arrd.1980.122.5.71.
5
The importance of particle size in response to inhaled bronchodilators.颗粒大小对吸入性支气管扩张剂反应的重要性。
Eur J Respir Dis Suppl. 1982;119:73-8.
6
Factors influencing the regional deposition of inhaled particles in man.
Clin Sci (Lond). 1983 Jan;64(1):69-78. doi: 10.1042/cs0640069.
7
The physiology of leaky lungs.肺渗漏的生理学
Br J Anaesth. 1982 Jul;54(7):705-21. doi: 10.1093/bja/54.7.705-a.
8
Clinical aerosols. I. Characterization of aerosols and their diagnostic uses.临床气雾剂。I. 气雾剂的特性及其诊断用途。
Arch Intern Med. 1982 Nov;142(12):2163-72.
9
Radionuclide demonstration of ventilatory abnormalities in mild asthma.
Clin Sci (Lond). 1984 May;66(5):525-31. doi: 10.1042/cs0660525.
10
Factors influencing the size distribution of aerosols from jet nebulisers.影响喷射式雾化器产生的气溶胶粒径分布的因素。
Thorax. 1983 Oct;38(10):755-9. doi: 10.1136/thx.38.10.755.